— Know what they know.
Not Investment Advice

SVRA NASDAQ

Savara Inc.
1W: -4.0% 1M: -1.6% 3M: -8.5% YTD: -10.3% 1Y: +61.1% 3Y: +134.3% 5Y: +224.4%
$5.02
-0.04 (-0.79%)
After Hours: $5.28 (+0.26, +5.18%)
Weekly Expected Move ±7.6%
$4 $5 $5 $5 $6
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 33 · $1.0B mcap · 106M float · 1.46% daily turnover · Short 73% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
-$245K +99.7% ▲
Operating Income
-$124M -19.7% ▼
Net Income
-$119M -23.9% ▼
EPS (Diluted)
$-0.53 -10.4% ▼
EBITDA
-$123M -20.7% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$0$0$0$0
YoY Growth-100.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$29M$28M$44M$78M$245K
Gross Profit-$29M-$28M-$44M-$78M-$245K
Gross Margin
R&D Expenses$29M$28M$44M$78M$81M
SG&A Expenses$12M$11M$16M$25M$42M
Operating Expenses$12M$11M$16M$25M$123M
Operating Income-$41M-$39M-$60M-$103M-$124M
Operating Margin
Interest Expense$2M$88K$0$0$0
Income Before Tax-$43M-$38M-$55M-$96M-$119M
Tax Expense$0$0$0$0$0
Net Income-$43M-$38M-$55M-$96M-$119M
Net Margin
EPS (Diluted)$-0.32$-0.25$-0.33$-0.48$-0.53
EBITDA-$40M-$38M-$59M-$102M-$123M
Shares Outstanding134M153M165M198M222M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms